Bioretec Ltd announced that it is revising its financial targets, deeming the current targets unachievable, and is withdrawing them.
On September 12, 2025, the company stated that the revised commercialization timeline of DrillPin in the U.S. would not significantly impact its financial targets published on October 4, 2024.
Bioretec is currently assessing and updating its commercialization strategy and pipeline, with an update expected by the end of 2025.
The company will provide an update by the end of 2025.
Author's summary: Bioretec revises financial targets.